一致性-话题@MedSci

#一致性#

148篇内容 | 2974人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1906905, encodeId=a1fa1906905b6, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=一致性评价政策要放宽？期限要改变？, objectType=article, longId=153624, objectId=1cd91536241c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cd91536241c, replyNumber=0, likeNumber=70, createdTime=2019-08-24, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cd91536241c, moduleTitle=一致性评价政策要放宽？期限要改变？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cd91536241c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906914, encodeId=c85e1906914d3, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=重磅！一致性评价年末大限取消, objectType=article, longId=156973, objectId=2e4a1569e3d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e4a1569e3d4, replyNumber=0, likeNumber=49, createdTime=2019-01-31, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e4a1569e3d4, moduleTitle=重磅！一致性评价年末大限取消, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e4a1569e3d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906878, encodeId=e91c19068e8b0, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=一致性评价后，12药品报价被公布, objectType=article, longId=144592, objectId=299a14459254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=299a14459254, replyNumber=0, likeNumber=74, createdTime=2019-03-03, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=299a14459254, moduleTitle=一致性评价后，12药品报价被公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=299a14459254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906891, encodeId=97871906891f6, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=定了！289品种年底未通过一致性评价直接淘汰！, objectType=article, longId=148278, objectId=7baf1482e8d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7baf1482e8d3, replyNumber=0, likeNumber=93, createdTime=2019-02-19, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7baf1482e8d3, moduleTitle=定了！289品种年底未通过一致性评价直接淘汰！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7baf1482e8d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906913, encodeId=9207190691326, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=4+7后，一致性评价将会发生7件事, objectType=article, longId=156829, objectId=6ec715682968, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ec715682968, replyNumber=0, likeNumber=0, createdTime=2019-06-09, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ec715682968, moduleTitle=4+7后，一致性评价将会发生7件事, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ec715682968)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906877, encodeId=cc2b19068e77a, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=喜报！通过一致性评价了......然后呢？, objectType=article, longId=144590, objectId=2e2a144590d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e2a144590d6, replyNumber=0, likeNumber=83, createdTime=2019-03-16, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e2a144590d6, moduleTitle=喜报！通过一致性评价了......然后呢？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e2a144590d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906869, encodeId=66a819068694b, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=仿制药再提速多地招采出新政支持一致性评价产品, objectType=article, longId=137701, objectId=d2f613e70171, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2f613e70171, replyNumber=0, likeNumber=79, createdTime=2018-07-18, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2f613e70171, moduleTitle=仿制药再提速多地招采出新政支持一致性评价产品, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2f613e70171)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906868, encodeId=27b719068685d, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=J Clin Oncol：兄弟间非低风险前列腺癌的一致性, objectType=article, longId=135428, objectId=2f9c135428f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f9c135428f5, replyNumber=0, likeNumber=90, createdTime=2018-10-19, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f9c135428f5, moduleTitle=J Clin Oncol：兄弟间非低风险前列腺癌的一致性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f9c135428f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906866, encodeId=4c4119068667f, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=2018前瞻预判！一致性评价、医保、医改、两票制有何新变化？, objectType=article, longId=129893, objectId=2d6a12989347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d6a12989347, replyNumber=0, likeNumber=64, createdTime=2018-12-31, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d6a12989347, moduleTitle=2018前瞻预判！一致性评价、医保、医改、两票制有何新变化？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d6a12989347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906886, encodeId=248e19068860b, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=未过一致性评价均不再采购千家药企受影响, objectType=article, longId=147415, objectId=53ef14e41508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53ef14e41508, replyNumber=0, likeNumber=57, createdTime=2019-01-23, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53ef14e41508, moduleTitle=未过一致性评价均不再采购千家药企受影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53ef14e41508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906870, encodeId=a11c19068e054, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=一致性评价药品特权落地，大批竞品危险了, objectType=article, longId=137755, objectId=538213e7558e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=538213e7558e, replyNumber=0, likeNumber=106, createdTime=2019-04-10, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=538213e7558e, moduleTitle=一致性评价药品特权落地，大批竞品危险了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=538213e7558e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906892, encodeId=744b190689221, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=基药目录调入调出仿制药直面一致性评价大洗牌, objectType=article, longId=148392, objectId=5c491483925c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c491483925c, replyNumber=0, likeNumber=54, createdTime=2019-05-16, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c491483925c, moduleTitle=基药目录调入调出仿制药直面一致性评价大洗牌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c491483925c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906899, encodeId=7fd9190689919, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=仿制药通过评价仅仅是补考及格，不要让一致性评价结果变味, objectType=article, longId=151663, objectId=ed8415166360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed8415166360, replyNumber=0, likeNumber=84, createdTime=2019-09-05, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed8415166360, moduleTitle=仿制药通过评价仅仅是补考及格，不要让一致性评价结果变味, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed8415166360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906898, encodeId=5cae190689891, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=日本仿制药一致性评价，地震后行业巨大提升, objectType=article, longId=151611, objectId=978715161142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=978715161142, replyNumber=0, likeNumber=82, createdTime=2019-09-08, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=978715161142, moduleTitle=日本仿制药一致性评价，地震后行业巨大提升, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=978715161142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906862, encodeId=7487190686290, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=注射剂一致性评价在即，葡萄糖酸钙注射液（10ml:1g）何去何从？, objectType=article, longId=128505, objectId=cbcd128505f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbcd128505f0, replyNumber=0, likeNumber=0, createdTime=2018-04-02, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbcd128505f0, moduleTitle=注射剂一致性评价在即，葡萄糖酸钙注射液（10ml:1g）何去何从？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbcd128505f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906860, encodeId=8c0f1906860d4, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=全面提升仿制药质量和疗效，首批17个品规通过一致性评价, objectType=article, longId=125647, objectId=193f12564e8e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=193f12564e8e, replyNumber=0, likeNumber=80, createdTime=2018-08-07, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=193f12564e8e, moduleTitle=全面提升仿制药质量和疗效，首批17个品规通过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=193f12564e8e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906874, encodeId=aa6719068e458, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=一致性评价药品危险了！承诺全国很低价, objectType=article, longId=142051, objectId=28791420514f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28791420514f, replyNumber=0, likeNumber=58, createdTime=2018-11-21, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28791420514f, moduleTitle=一致性评价药品危险了！承诺全国很低价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28791420514f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906856, encodeId=43f51906856d0, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=来了！注射剂一致性评价！, objectType=article, longId=124459, objectId=a32e124459f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a32e124459f7, replyNumber=0, likeNumber=64, createdTime=2018-09-29, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a32e124459f7, moduleTitle=来了！注射剂一致性评价！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a32e124459f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906857, encodeId=1c51190685e10, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=重磅！首批通过一致性评价品种名单出炉，华海药业是很大赢家, objectType=article, longId=125064, objectId=11471250646d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11471250646d, replyNumber=0, likeNumber=59, createdTime=2018-05-02, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11471250646d, moduleTitle=重磅！首批通过一致性评价品种名单出炉，华海药业是很大赢家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11471250646d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906872, encodeId=ae8419068e224, content=<a href='/topic/show?id=d91e1943441' target=_blank style='color:#2F92EE;'>#一致性#</a>, objectTitle=立普妥危险了！首仿阿乐通过一致性评价，2020目标单品破百亿, objectType=article, longId=138751, objectId=5ae2138e51c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ae2138e51c2, replyNumber=0, likeNumber=70, createdTime=2019-04-04, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ae2138e51c2, moduleTitle=立普妥危险了！首仿阿乐通过一致性评价，2020目标单品破百亿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ae2138e51c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

一致性

2020-05-29

zhanfl (审核中...)

前往app查看评论内容

#一致性#

一致性评价政策要放宽？期限要改变？

2019-08-24

zhanfl (审核中...)

前往app查看评论内容

#一致性#

重磅！一致性评价年末大限取消

2019-01-31

zhanfl (审核中...)

前往app查看评论内容

#一致性#

一致性评价后，12药品报价被公布

2019-03-03

zhanfl (审核中...)

前往app查看评论内容

#一致性#

定了！289品种年底未通过一致性评价直接淘汰！

2019-02-19

zhanfl (审核中...)

前往app查看评论内容

#一致性#

4+7后，一致性评价将会发生7件事

2019-06-09

zhanfl (审核中...)

前往app查看评论内容

#一致性#

喜报！通过一致性评价了......然后呢？

2019-03-16

zhanfl (审核中...)

前往app查看评论内容

#一致性#

仿制药再提速多地招采出新政支持一致性评价产品

2018-07-18

zhanfl (审核中...)

前往app查看评论内容

#一致性#

J Clin Oncol：兄弟间非低风险前列腺癌的一致性

2018-10-19

zhanfl (审核中...)

前往app查看评论内容

#一致性#

2018前瞻预判！一致性评价、医保、医改、两票制有何新变化？

2018-12-31

zhanfl (审核中...)

前往app查看评论内容

#一致性#

未过一致性评价均不再采购千家药企受影响

2019-01-23

zhanfl (审核中...)

前往app查看评论内容

#一致性#

一致性评价药品特权落地，大批竞品危险了

2019-04-10

zhanfl (审核中...)

前往app查看评论内容

#一致性#

基药目录调入调出仿制药直面一致性评价大洗牌

2019-05-16

zhanfl (审核中...)

前往app查看评论内容

#一致性#

仿制药通过评价仅仅是补考及格，不要让一致性评价结果变味

2019-09-05

zhanfl (审核中...)

前往app查看评论内容

#一致性#

日本仿制药一致性评价，地震后行业巨大提升

2019-09-08

zhanfl (审核中...)

前往app查看评论内容

#一致性#

注射剂一致性评价在即，葡萄糖酸钙注射液（10ml:1g）何去何从？

2018-04-02

zhanfl (审核中...)

前往app查看评论内容

#一致性#

全面提升仿制药质量和疗效，首批17个品规通过一致性评价

2018-08-07

zhanfl (审核中...)

前往app查看评论内容

#一致性#

一致性评价药品危险了！承诺全国很低价

2018-11-21

zhanfl (审核中...)

前往app查看评论内容

#一致性#

来了！注射剂一致性评价！

2018-09-29

zhanfl (审核中...)

前往app查看评论内容

#一致性#

重磅！首批通过一致性评价品种名单出炉，华海药业是很大赢家

2018-05-02

zhanfl (审核中...)

前往app查看评论内容

#一致性#

立普妥危险了！首仿阿乐通过一致性评价，2020目标单品破百亿

2019-04-04

科室
- - 订阅+
  - 更多科室
工具
服务